Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:amoxicillin
|
| gptkbp:approvalYear |
2008
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
J01CA04
|
| gptkbp:contraindication |
hypersensitivity to penicillins
|
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
penicillin antibiotic
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:form |
extended-release tablet
|
| gptkbp:halfLife |
1-1.5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Moxatag
|
| gptkbp:indication |
tonsillitis
pharyngitis |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:MiddleBrook_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
Rx-only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea rash |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:Amoxicillin
|
| gptkbp:bfsLayer |
5
|